Filing metadata

Accession number
0001209191-22-039568
Form type
Form 4
Filer
Ultragenyx Pharmaceutical Inc.
CIK
CIK 1515673
Filed
Jun 28, 2022
Reporting period
Jun 24, 2022
Description
Insider transaction

Explore SEC Filings Hub